What physicians should know about FDA's new proposed guidance ...
Drug Safety Monitoring Board (DSMB) gives Noveome Biotherapeutics a recommendation to continue the Necrotizing ...
DelveInsight’s, “Hepatic Tumor Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and ...
Renowned clinical researcher and CEO of the Baim Institute Dr. Gibson joins DrKumo to drive innovation in pharma ...
Designed to encourage interaction and collaboration, SCOPE X emphasizes detailed case studies, peer-driven discussions, and ...
RLS-1496 was well-tolerated, with no serious adverse events (AEs) and no discontinuations due to AEs or tolerability issues during the 4-week study In psoriasis patients: Dose-dependent target ...
Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...
A new wearable device, developed by an Australian company, looks to upgrade labor and delivery technology for the first time ...
An expansive clinical trial led by USF researchers and aimed at delaying the onset of dementia continues to receive major ...
A new class of weight loss drug just took a major step toward approval for use. In a phase III clinical trial, medication ...
Results from the OASIS 4 clinical trial show that a new drug, elinzanetant, relieved hot flashes and night sweats that can ...